Effets métaboliques différentiels des sucres, Cah. Nutr. Diet. Hors, vol.2, issue.43, 2008. ,
Métabolisme du glucose en situation physiologique. annales françaises d'anesthésie et de réanimation, 2009. ,
DOI : 10.1016/j.annfar.2009.02.031
Les principaux transporteurs du glucose et de leur localisation, 2012. ,
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase, Nature Medicine, vol.276, issue.11, pp.1288-95, 2002. ,
DOI : 10.1074/jbc.M005816200
URL : https://hal.archives-ouvertes.fr/hal-00174612
Role of AMP-activated protein kinase in mechanism of metformin action, Journal of Clinical Investigation, vol.108, issue.8, pp.1167-74, 2001. ,
DOI : 10.1172/JCI13505
Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle, Journal of Applied Physiology, vol.88, issue.3, pp.1017-1045, 2001. ,
DOI : 10.1152/ajpendo.2000.279.3.E622
Les effets de l'insuline: de la cellule à l'organisme entier. Annales françaises d'anesthésie et de réanimation, 2009. ,
Hormones d'origine digestive, Pharmacorama. [En ligne] CdM Editions, 2000. ,
Les hormones du tube digestif, Diabète&Obésité. Janvier, vol.2, p.5, 2007. ,
Inhibiteurs du cotransporteur du glucose SGLT2 rénal pour traiter le diabète de type 2, Rev Med Suisse, vol.7, pp.1621-1629, 2011. ,
Hypoglycémies: aspects cliniques et stratégie ,
Effect of Antecedent Hypoglycemia on Counterregulatory Responses to Subsequent Euglycemic Exercise in Type 1 Diabetes, Diabetes, vol.52, issue.7, pp.1761-1770, 2003. ,
DOI : 10.2337/diabetes.52.7.1761
SYMPTOMS OF HYPOGLYCEMIA, THRESHOLDS FOR THEIR OCCURRENCE, AND HYPOGLYCEMIA UNAWARENESS, Endocrinology and Metabolism Clinics of North America, vol.28, issue.3, pp.495-500, 1999. ,
DOI : 10.1016/S0889-8529(05)70084-0
Effects of Differing Antecedent Hypoglycemia on Subsequent Counterregulation in Normal Humans, Diabetes, vol.46, issue.8, pp.1328-1363, 1997. ,
DOI : 10.2337/diab.46.8.1328
Hypoglycémies du nourrisson et de l'enfant, Rev. Prat, vol.35, p.31, 1985. ,
Les hypoglycémies médicamenteuses, Rev. Prat, vol.35, p.31, 1985. ,
Le syndrome d'hypoglycémie réactionnelle, mythe ou réalité Journées annuelles de diabétologie de l'Hôtel- Dieu. Flammarion éd, pp.111-118, 1983. ,
Postprandial Hypoglycemia, Diabetes, vol.25, issue.8, pp.719-733, 1976. ,
DOI : 10.2337/diab.25.8.719
Hypoglycémie non diabétique : diagnostic et prise en charge, Rev Med Suisse, vol.9, pp.1186-1191, 2013. ,
NOCTURNAL HYPOGLYCEMIA: CLINICAL MANIFESTATIONS AND THERAPEUTIC STRATEGIES TOWARD PREVENTION, Endocrine Practice, vol.9, issue.6, pp.530-573, 2003. ,
DOI : 10.4158/EP.9.6.530
La fin du cauchemar : la prévention de l'hypoglycémie nocturne chez l'enfant. Diabetes Voice, 2007. ,
Le diabete et l'insuffisance rénale. La Fondation Canadienne du Rein, 2009. ,
Facultés de Médecine de Toulouse. [En ligne] [Citation : 14 07, 2014. ,
Place de l'octréotide dans le traitement des hypoglycémies induites par les sulfonylurées, Rev Med Suisse, vol.4, pp.1764-1767, 2008. ,
Evaluation of the Use and Safety of Octreotide as Antidotal Therapy for Sulfonylurea Overdose in Children, Pediatric Emergency Care, vol.29, issue.3, pp.292-297 ,
DOI : 10.1097/PEC.0b013e31828503cf
Octreotide reverse hyperinsulinemia and prevents hypoglycemia induced by sulfonylureas overdose, J Clin Endocrinol Metab, vol.76, pp.752-758, 1993. ,
DOI : 10.1210/jc.76.3.752
Euglycemia after Late Octreotide Use in Pediatric Glipizide Toxicity. North American Congress of Clinical Toxicology: abstr. 244 : s.n, 2010. ,
Weighing the potential benefits and risks of antidiabetic agents in older adults. Diabetes spectrum 25, pp.172-179, 2012. ,
Hypoglycémiants -Autres médicaments, Pharmacorama. [En ligne] CdM Editions, 2000. ,
Rôle et place des analogues du GLP-1 dans le traitement du diabète de type 2. Revue Médicale Suisse, pp.8-10, 2009. ,
Les gliptines, sitagliptine et vildagliptine, antidiabétiques. Pharmacorama. [En ligne] [Citation : 08 10 2014 ,
Inhibiteurs de l'enzyme de conversion de l'angiotensine. Pharmacorama. [En ligne] [Citation : 01 10, 2014. ,
Pancreatic Islet Renin Angiotensin System, Pancreas, vol.30, issue.4, pp.293-301, 2005. ,
DOI : 10.1097/01.mpa.0000158028.76666.76
Angiotensin Type 1 Receptor Blockers Induce Peroxisome Proliferator-Activated Receptor-?? Activity, Circulation, vol.109, issue.17, pp.2054-2061, 2004. ,
DOI : 10.1161/01.CIR.0000127955.36250.65
URL : http://circ.ahajournals.org/content/circulationaha/109/17/2054.full.pdf
Replacement of Valsartan and Candesartan by Telmisartan in Hypertensive Patients With Type 2 Diabetes: Metabolic and antiatherogenic consequences, Diabetes Care, vol.28, issue.3, pp.757-765, 2005. ,
DOI : 10.2337/diacare.28.3.757
Evidences for a direct stimulatoy effect of cibenzoline on insulin secretion in rats, Eur J Pharmacol ,
Extremely Prolonged Elimination of Cibenzoline at Toxic Plasma Concentrations in Patients With Renal Impairments, Therapeutic Drug Monitoring, vol.24, issue.4, pp.492-496, 2002. ,
DOI : 10.1097/00007691-200208000-00005
Hypoglycemia caused by overdose of a new anti-arrhythmia agent: cibenzoline, Press Med, vol.17, issue.14, pp.687-91, 1988. ,
Hypoglycemia in patient receving disopyramide phosphate. Drug Intelligence and Clinical Pharmacy, pp.635-638, 1985. ,
DOI : 10.1177/106002808301700905
Disopyramide (Norpace??)-induced hypoglycemia, The American Journal of Medicine, vol.69, issue.3, pp.463-466, 1980. ,
DOI : 10.1016/0002-9343(80)90020-0
Disopyramide induced profound hypoglycemia, N.Y. State J Med, vol.83, pp.10527-10555, 1983. ,
Refractory hypoglycemia: a complication of topical salicylate therapy. Archives of Dermatology, pp.1455-1457, 1994. ,
Drug-Induced Hypoglycemia ,
DOROSZ Guide pratique des médicaments ,
Improvement of type 2 diabetes in a lung cancer patient treated with erlotinib. Diabetes Care, p.1711, 2006. ,
Symptomatic hypoglycemia during imatinib mesylate in a non-diabetic female patient with gastrointestinal stromal tumor, Journal of Endocrinological Investigation, vol.24, issue.3, pp.688-692, 2007. ,
DOI : 10.1200/JCO.2006.06.5318
Hypoglycemia in a patient with metastatic gastrointestinal stromal tumor: Is chemotherapy a reasonable option for symptom control? Uluslararasi Hematoloji-Onkoloji Dergisi, pp.48-51 ,
[En ligne] [Citation : 27 10 2014 ,
Antibiotiques agissant sur la paroi des mycobactéries - Antituberculeux. Pharmacorama. [En ligne] [Citation : 01 10, 2014. ,
Effects of fluoroquinolones on insulin secretion and beta-cell, Science Direct. European Journal of Pharmacology, vol.497, 2004. ,
Hypoglycemia associated with the use of levofloxacin American journal of health-system pharmacy : AJHP : official journal of the, pp.1014-1023, 2009. ,
Doxycycline-Induced Hypoglycemia in a Nondiabetic Young Man, Southern Medical Journal, vol.95, issue.11, pp.1353-1354, 2002. ,
DOI : 10.1097/00007611-200295110-00026
[Citation : 05 06 2014, 2000. ,
The safety of fluoxetine-An update, J. Psychiatry, vol.153, issue.3, pp.77-86, 1988. ,
The side effect profile and safety of fluoxetine, J Clin Psychiatry, vol.46, issue.2, pp.59-67, 1985. ,
Hypoglycemia associated with the use of Fluoxetine, 1996. ,
Sérotoninomimétiques indirects. Pharmacorama. [En ligne] [Citation : 21 10, 2014. ,
La gestion du risque médicamenteux grave. La revue Prescrire, p.343, 2012. ,
En ligne] [Citation : 12 12 2013ansm.sante.fr/Declarer-un-effet- indesirable/Pharmacovigilance/Organisation-de-la-pharmacovigilance- nationale/%28offset%29/0. 73. insulines, 1998. ,
Fiche pratique - Pharmaco-thérapeutique -Bêta-bloquants. [En ligne] 17 11 2011. [Citation : 20 02, 2015. ,